Free Trial

ADC Therapeutics (ADCT) Institutional Ownership

ADC Therapeutics logo
$3.38 -0.11 (-3.02%)
Closing price 03:59 PM Eastern
Extended Trading
$3.36 -0.01 (-0.30%)
As of 05:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Institutional Ownership Changes (13F Filings) for ADC Therapeutics (NYSE:ADCT)

Current
Institutional Ownership
Percentage
41.10%
Number of
Institutional Buyers
(last 12 months)
43
Total
Institutional Inflows
(last 12 months)
$60.76M
Number of
Institutional Sellers
(last 12 months)
29
Total
Institutional Outflows
(last 12 months)
$36.82M
Get ADCT Insider Trade Alerts

Want to know when executives and insiders are buying or selling ADC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

ADCT Institutional Buying and Selling by Quarter

ADC Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2026Sei Investments Co.33,461$125K0.0%+45.6%0.026%
5/14/2026 Walleye Capital LLC77,390$290K0.0%N/A0.061%
5/5/2026 Bank of New York Mellon Corp202,254$758K0.0%+16.9%0.159%
4/29/2026 R Squared Ltd10,119$38K0.0%N/A0.008%
2/18/2026XTX Topco Ltd82,871$293K0.0%-9.5%0.067%
2/18/2026Orbimed Advisors LLC5,822,854$20.56M0.4%-1.4%4.700%
2/18/2026Millennium Management LLC328,429$1.16M0.0%-53.2%0.265%
2/18/2026Engineers Gate Manager LP12,071$43K0.0%N/A0.010%
2/17/2026AQR Capital Management LLC206,576$729K0.0%+42.2%0.167%
2/17/2026Cantor Fitzgerald L. P.100,000$353K0.0%N/A0.081%
2/17/2026Jump Financial LLC162,250$573K0.0%+1,299.8%0.131%
2/17/2026Price T Rowe Associates Inc. MD46,750$166K0.0%+25.6%0.038%
2/17/2026 Russell Investments Group Ltd.24,532$87K0.0%-24.5%0.020%
2/17/2026State of Wisconsin Investment Board113,369$400K0.0%N/A0.092%
2/17/2026ExodusPoint Capital Management LP56,783$200K0.0%+23.6%0.046%
2/16/2026Panagora Asset Management Inc.594,256$2.10M0.0%+9.2%0.480%
2/16/2026Eventide Asset Management LLC3,364,067$11.88M0.2%N/A2.716%
2/16/2026Barclays PLC161,386$570K0.0%+23.7%0.130%
2/13/2026Prosight Management LP8,477,338$29.93M6.2%+13.5%6.843%
2/13/2026Nantahala Capital Management LLC5,475,433$19.33M0.6%+141.6%4.420%
2/13/2026Schroder Investment Management Group418,782$1.47M0.0%N/A0.338%
2/13/2026Charles Schwab Investment Management Inc.212,668$751K0.0%+16.8%0.172%
2/13/2026State Street Corp1,407,325$4.97M0.0%+8.6%1.136%
2/13/2026Ieq Capital LLC16,067$57K0.0%-22.0%0.013%
2/13/2026 Wells Fargo & Company MN320,048$1.13M0.0%+360.5%0.258%
2/13/2026Platinum Investment Management Ltd.990,778$3.50M0.8%-14.3%0.800%
2/12/2026 Jane Street Group LLC199,764$705K0.0%-59.1%0.161%
2/12/2026MetLife Investment Management LLC49,682$175K0.0%+65.3%0.040%
2/12/2026 Commonwealth Equity Services LLC17,809$63K0.0%-21.9%0.014%
2/12/2026 Nuveen LLC118,915$420K0.0%-30.6%0.096%
2/11/2026 Deutsche Bank AG70,774$250K0.0%-8.7%0.057%
2/11/2026 LPL Financial LLC31,900$113K0.0%-29.3%0.026%
2/10/2026Goldman Sachs Group Inc.1,640,872$5.79M0.0%+2.9%1.325%
2/10/2026AXQ Capital LP16,078$57K0.0%N/A0.013%
2/9/2026Geode Capital Management LLC996,523$3.52M0.0%+15.5%0.804%
2/6/2026 ProShare Advisors LLC15,727$56K0.0%+27.0%0.013%
1/28/2026 Kingswood Wealth Advisors LLC105,000$371K0.0%N/A0.085%
1/9/2026 SG Americas Securities LLC24,448$86K0.0%N/A0.020%
1/7/2026 Henrickson Nauta Wealth Advisors Inc.19,411$69K0.0%N/A0.016%
1/1/2026JPMorgan Chase & Co.330,597$1.32M0.0%+865.3%0.267%
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (Ad)

Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The Financial Times estimates this move could help unleash $100 trillion in new wealth. Billionaire investors John Paulson, Ray Dalio, and Paul Tudor Jones are already said to be preparing. The window to get ahead of this may be closing.tc pixel

Click here to see the full details before May 15
11/18/2025Heights Capital Management Inc.326,766$1.31M0.4%-88.5%0.264%
11/17/2025TCG Crossover Management LLC1,390,175$5.56M0.3%N/A1.122%
11/17/2025Voleon Capital Management LP70,311$281K0.0%N/A0.057%
11/17/2025Millennium Management LLC701,619$2.81M0.0%+82.9%0.566%
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.34,045$136K0.0%-14.1%0.027%
11/17/2025Bank of America Corp DE1,361,290$5.45M0.0%-38.1%1.099%
11/14/2025 Creative Planning106,651$427K0.0%+196.3%0.086%
11/14/2025Two Sigma Investments LP45,458$182K0.0%N/A0.037%
11/14/2025Squarepoint Ops LLC174,943$700K0.0%+550.8%0.141%
11/14/2025Prosight Management LP7,472,303$29.89M7.0%-28.6%6.032%
11/13/2025Platinum Investment Management Ltd.1,156,721$4.63M0.3%-16.6%0.934%
11/13/2025 Lynx1 Capital Management LP1,325,848$5.30M1.0%N/A1.179%
11/13/2025 UBS Group AG262,261$1.05M0.0%-68.3%0.233%
11/13/2025 BNP Paribas Financial Markets688,471$2.75M0.0%+15.2%0.612%
11/13/2025 Russell Investments Group Ltd.32,502$130K0.0%+31.1%0.029%
11/12/2025 R Squared Ltd14,714$59K0.0%N/A0.013%
11/7/2025Vanguard Group Inc.593,954$2.38M0.0%+6.0%0.528%
11/7/2025JPMorgan Chase & Co.330,597$1.32M0.0%+865.3%0.294%
10/17/2025 Ethic Inc.15,207$61K0.0%-59.8%0.014%
10/9/2025 Voya Investment Management LLC13,570$54K0.0%-38.1%0.012%
9/26/2025Corient Private Wealth LLC357,880$959K0.0%N/A0.318%
8/15/2025Corient Private Wealth LLC357,880$959K0.0%N/A0.318%
8/15/2025 BNP Paribas Financial Markets597,792$1.60M0.0%-13.6%0.531%
8/15/2025Bank of America Corp DE2,199,059$5.89M0.0%+22.1%1.955%
8/14/2025Nantahala Capital Management LLC2,266,289$6.07M0.2%N/A2.285%
8/14/2025Orbimed Advisors LLC5,907,351$15.83M0.4%-1.0%5.956%
8/14/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.39,633$106K0.0%-18.4%0.040%
8/14/2025The Manufacturers Life Insurance Company 25,740$69K0.0%-13.3%0.026%
8/14/2025Stempoint Capital LP283,286$759K0.2%N/A0.286%
8/13/2025Panagora Asset Management Inc.271,359$727K0.0%+400.8%0.274%
8/13/2025 Russell Investments Group Ltd.24,801$66K0.0%-37.5%0.025%
8/12/2025 Rhumbline Advisers102,608$275K0.0%-8.1%0.103%
8/12/2025JPMorgan Chase & Co.34,247$92K0.0%-13.8%0.035%
8/12/2025Magnetar Financial LLC39,092$105K0.0%-29.9%0.039%
8/8/2025 Intech Investment Management LLC36,181$97K0.0%-42.5%0.036%
8/8/2025 Creative Planning35,999$96K0.0%N/A0.036%
8/8/2025Geode Capital Management LLC858,796$2.30M0.0%-11.4%0.866%
7/30/2025 Ethic Inc.37,862$103K0.0%N/A0.038%
7/25/2025CWM LLC9,981$27K0.0%-25.0%0.010%
7/21/2025Platinum Investment Management Ltd.1,387,265$3.72M0.2%-31.9%1.399%
7/10/2025 Wealth Enhancement Advisory Services LLC11,232$32K0.0%-25.1%0.011%
5/16/2025Woodline Partners LP815,531$1.15M0.0%-57.8%0.822%
5/16/2025Goldman Sachs Group Inc.1,583,112$2.23M0.0%-5.4%1.596%
5/16/2025AQR Capital Management LLC201,170$284K0.0%+411.1%0.203%
5/14/2025MetLife Investment Management LLC45,487$64K0.0%+46.2%0.046%
5/13/2025Russell Investments Group Ltd.39,688$56K0.0%+136.3%0.040%
5/12/2025Nuveen LLC152,047$214K0.0%N/A0.153%
5/12/2025Invesco Ltd.132,704$187K0.0%+286.1%0.134%
5/9/2025Atria Wealth Solutions Inc.20,000$28K0.0%N/A0.020%
4/30/2025Cerity Partners LLC17,912$25K0.0%N/A0.018%
Iran War Update: Trump’s Hand-Written Letter Reveals What Comes Next (Ad)

Jim Rickards has uncovered what he believes is Trump's economic plan, with a key trigger date of May 15. The Financial Times estimates this move could help unleash $100 trillion in new wealth. Billionaire investors John Paulson, Ray Dalio, and Paul Tudor Jones are already said to be preparing. The window to get ahead of this may be closing.tc pixel

Click here to see the full details before May 15
4/29/2025Bank of New York Mellon Corp159,466$225K0.0%-7.3%0.161%
3/24/2025Wellington Management Group LLP253,342$504K0.0%+50.3%0.262%
2/17/2025Woodline Partners LP1,933,751$3.85M0.0%N/A2.000%
2/17/2025Squarepoint Ops LLC107,231$213K0.0%+42.2%0.111%
2/17/2025Two Sigma Advisers LP65,267$130K0.0%+122.9%0.068%
2/17/2025Two Sigma Investments LP183,231$365K0.0%-25.3%0.190%
2/17/2025ProShare Advisors LLC22,901$46K0.0%+49.0%0.024%
2/17/2025Prosight Management LP9,515,000$18.94M5.2%-1.3%9.841%
2/17/2025Nuveen Asset Management LLC152,047$303K0.0%+17.8%0.157%
2/17/2025Orbimed Advisors LLC5,968,451$11.88M0.3%+31.6%6.173%


ADCT Institutional Ownership - Frequently Asked Questions

During the previous two years, 83 institutional investors and hedge funds held shares of ADC Therapeutics. The most heavily invested institutionals were Redmile Group LLC ($49.36M), Prosight Management LP ($29.93M), Orbimed Advisors LLC ($20.56M), Nantahala Capital Management LLC ($19.33M), Eventide Asset Management LLC ($11.88M), Goldman Sachs Group Inc. ($5.79M), and TCG Crossover Management LLC ($5.56M).Learn more on ADC Therapeutics' institutional investors.

41.10% of ADC Therapeutics' stock is owned by institutional investors. Learn more on ADCT's institutional investor holdings.

Of the 73 institutional investors that purchased ADC Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Nantahala Capital Management LLC ($5.48M), Eventide Asset Management LLC ($3.36M), Woodline Partners LP ($1.93M), Orbimed Advisors LLC ($1.43M), TCG Crossover Management LLC ($1.39M), Lynx1 Capital Management LP ($1.33M), and Prosight Management LP ($1.01M).

Institutional investors have bought a total of 17,647,278 shares in the last 24 months. This purchase volume represents approximately $60.76M in transactions.

Of the 29 institutional investors that sold ADC Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Prosight Management LP ($3.00M), Heights Capital Management Inc. ($2.51M), Woodline Partners LP ($1.12M), Platinum Investment Management Ltd. ($1.05M), Bank of America Corp DE ($837.77K), UBS Group AG ($565.31K), and Millennium Management LLC ($373.19K).

Institutional investors have sold a total of 10,400,141 shares in the last 24 months. This volume of shares sold represents approximately $36.82M in transactions.



This page (NYSE:ADCT) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners